Top segments and regional performance

Last year, the company generated ‪11.97 B‬ USD, the most of which — ‪11.97 B‬ USD — came from its top-performing segment, Pharmaceuticals, compared to ‪11.02 B‬ USD the previous year. The greatest contribution came from United States, which accounted for ‪7.55 B‬ USD last year, with ‪6.68 B‬ USD the year before.